We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Waxman Encourages FDA to Act on Follow-On Biologics
Waxman Encourages FDA to Act on Follow-On Biologics
February 25, 2005
Although Rep. Henry Waxman (D-Calif.) continues to support the Hatch-Waxman Act, he acknowledged last week that the law is not a complete solution to the problems generic drugmakers face in trying to bring new products to market, particularly generic biologic products.